<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Breathe Life - Interactive Lung Cancer Awareness</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', 'Inter', Roboto, sans-serif;
            line-height: 1.6;
            color: #1a1a1a;
        }

        /* Navigation */
        nav {
            position: fixed;
            top: 0;
            width: 100%;
            background: rgba(255, 255, 255, 0.95);
            backdrop-filter: blur(10px);
            z-index: 1000;
            box-shadow: 0 2px 20px rgba(0, 0, 0, 0.05);
        }

        .nav-container {
            max-width: 1400px;
            margin: 0 auto;
            padding: 1rem 2rem;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .logo {
            font-size: 1.5rem;
            font-weight: 700;
            background: linear-gradient(135deg, #0ea5e9 0%, #06b6d4 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            cursor: pointer;
        }

        .nav-links {
            display: flex;
            gap: 2rem;
            list-style: none;
        }

        .nav-links a {
            color: #1a1a1a;
            text-decoration: none;
            font-weight: 500;
            transition: all 0.3s;
            cursor: pointer;
            position: relative;
        }

        .nav-links a.active {
            color: #0ea5e9;
        }

        .page {
            display: none;
            min-height: 100vh;
            padding-top: 80px;
        }

        .page.active {
            display: block;
            animation: fadeIn 0.5s;
        }

        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }

        /* Hero */
        .hero {
            min-height: 90vh;
            display: flex;
            align-items: center;
            background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 50%, #dbeafe 100%);
            position: relative;
            overflow: hidden;
        }

        .hero-content {
            max-width: 1400px;
            margin: 0 auto;
            padding: 4rem 2rem;
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 4rem;
            align-items: center;
        }

        .hero-text h1 {
            font-size: 4rem;
            font-weight: 800;
            line-height: 1.1;
            margin-bottom: 1.5rem;
            background: linear-gradient(135deg, #0c4a6e 0%, #0ea5e9 50%, #06b6d4 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
        }

        .btn-primary {
            background: linear-gradient(135deg, #0ea5e9 0%, #06b6d4 100%);
            color: white;
            padding: 1rem 2.5rem;
            border-radius: 50px;
            font-weight: 600;
            font-size: 1.1rem;
            transition: all 0.3s;
            box-shadow: 0 10px 30px rgba(14, 165, 233, 0.3);
            cursor: pointer;
            border: none;
            display: inline-block;
        }

        .btn-primary:hover {
            transform: translateY(-3px);
            box-shadow: 0 15px 40px rgba(14, 165, 233, 0.4);
        }

        /* Content Pages */
        .content-page {
            padding: 4rem 2rem;
            max-width: 1200px;
            margin: 0 auto;
        }

        .page-header {
            text-align: center;
            margin-bottom: 4rem;
        }

        .page-header h1 {
            font-size: 3.5rem;
            font-weight: 800;
            background: linear-gradient(135deg, #0c4a6e 0%, #0ea5e9 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            margin-bottom: 1rem;
        }

        /* Tabs */
        .tabs {
            display: flex;
            gap: 1rem;
            margin-bottom: 2rem;
            border-bottom: 2px solid #e2e8f0;
            overflow-x: auto;
        }

        .tab {
            padding: 1rem 2rem;
            cursor: pointer;
            border: none;
            background: none;
            font-size: 1.1rem;
            font-weight: 600;
            color: #64748b;
            transition: all 0.3s;
            border-bottom: 3px solid transparent;
            white-space: nowrap;
        }

        .tab.active {
            color: #0ea5e9;
            border-bottom-color: #0ea5e9;
        }

        .tab-content {
            display: none;
        }

        .tab-content.active {
            display: block;
            animation: fadeIn 0.5s;
        }

        /* Accordion */
        .accordion {
            margin: 2rem 0;
        }

        .accordion-item {
            background: white;
            border-radius: 12px;
            margin-bottom: 1rem;
            border: 1px solid #e2e8f0;
            overflow: hidden;
            transition: all 0.3s;
        }

        .accordion-item:hover {
            border-color: #0ea5e9;
            box-shadow: 0 4px 20px rgba(14, 165, 233, 0.1);
        }

        .accordion-header {
            padding: 1.5rem;
            cursor: pointer;
            display: flex;
            justify-content: space-between;
            align-items: center;
            font-weight: 600;
            color: #0c4a6e;
            font-size: 1.2rem;
            user-select: none;
        }

        .accordion-icon {
            font-size: 1.5rem;
            transition: transform 0.3s;
        }

        .accordion-item.active .accordion-icon {
            transform: rotate(180deg);
        }

        .accordion-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.3s ease-out;
            padding: 0 1.5rem;
            color: #64748b;
            line-height: 1.8;
        }

        .accordion-item.active .accordion-content {
            padding: 0 1.5rem 1.5rem;
        }

        /* Interactive Cards */
        .card-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 2rem;
            margin: 2rem 0;
        }

        .interactive-card {
            background: white;
            border-radius: 20px;
            padding: 2rem;
            box-shadow: 0 8px 30px rgba(0, 0, 0, 0.08);
            transition: all 0.4s;
            border: 2px solid #e2e8f0;
            cursor: pointer;
            position: relative;
            overflow: hidden;
        }

        .interactive-card::before {
            content: '';
            position: absolute;
            top: 0;
            left: -100%;
            width: 100%;
            height: 100%;
            background: linear-gradient(90deg, transparent, rgba(14, 165, 233, 0.1), transparent);
            transition: left 0.5s;
        }

        .interactive-card:hover::before {
            left: 100%;
        }

        .interactive-card:hover {
            border-color: #0ea5e9;
            transform: translateY(-8px);
            box-shadow: 0 15px 45px rgba(14, 165, 233, 0.2);
        }

        .card-icon {
            font-size: 3rem;
            margin-bottom: 1rem;
        }

        .card-title {
            font-size: 1.5rem;
            font-weight: 700;
            color: #0c4a6e;
            margin-bottom: 1rem;
        }

        /* Risk Calculator */
        .calculator {
            background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
            border-radius: 24px;
            padding: 3rem;
            margin: 3rem 0;
        }

        .calculator h3 {
            font-size: 2rem;
            color: #0c4a6e;
            margin-bottom: 2rem;
            text-align: center;
        }

        .question {
            margin-bottom: 2rem;
        }

        .question label {
            display: block;
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 1rem;
            font-size: 1.1rem;
        }

        .question select, .question input {
            width: 100%;
            padding: 1rem;
            border: 2px solid #e2e8f0;
            border-radius: 12px;
            font-size: 1rem;
            transition: all 0.3s;
        }

        .question select:focus, .question input:focus {
            outline: none;
            border-color: #0ea5e9;
            box-shadow: 0 0 0 3px rgba(14, 165, 233, 0.1);
        }

        .risk-result {
            background: white;
            padding: 2rem;
            border-radius: 16px;
            margin-top: 2rem;
            text-align: center;
            display: none;
        }

        .risk-result.show {
            display: block;
            animation: fadeIn 0.5s;
        }

        .risk-level {
            font-size: 3rem;
            font-weight: 800;
            margin: 1rem 0;
        }

        .risk-low { color: #10b981; }
        .risk-medium { color: #f59e0b; }
        .risk-high { color: #ef4444; }

        /* Testimonials Slider */
        .testimonials {
            background: linear-gradient(135deg, #0c4a6e 0%, #0ea5e9 100%);
            padding: 4rem 2rem;
            color: white;
            position: relative;
            overflow: hidden;
        }

        .testimonial-container {
            max-width: 900px;
            margin: 0 auto;
            position: relative;
        }

        .testimonial {
            display: none;
            text-align: center;
            padding: 2rem;
        }

        .testimonial.active {
            display: block;
            animation: fadeIn 0.5s;
        }

        .testimonial-text {
            font-size: 1.5rem;
            line-height: 1.8;
            margin-bottom: 2rem;
            font-style: italic;
        }

        .testimonial-author {
            font-size: 1.2rem;
            font-weight: 600;
        }

        .slider-controls {
            display: flex;
            justify-content: center;
            gap: 1rem;
            margin-top: 2rem;
        }

        .slider-btn {
            width: 50px;
            height: 50px;
            border-radius: 50%;
            background: rgba(255, 255, 255, 0.2);
            border: 2px solid white;
            color: white;
            font-size: 1.5rem;
            cursor: pointer;
            transition: all 0.3s;
        }

        .slider-btn:hover {
            background: white;
            color: #0ea5e9;
        }

        /* FAQ Section */
        .faq-section {
            background: #f8fafc;
            padding: 4rem 2rem;
        }

        .faq-container {
            max-width: 900px;
            margin: 0 auto;
        }

        /* Progress Bar */
        .progress-bar {
            width: 100%;
            height: 8px;
            background: #e2e8f0;
            border-radius: 10px;
            overflow: hidden;
            margin: 2rem 0;
        }

        .progress-fill {
            height: 100%;
            background: linear-gradient(90deg, #0ea5e9, #06b6d4);
            transition: width 0.5s ease;
        }

        /* Stats Counter */
        .stats-section {
            padding: 4rem 2rem;
            background: white;
        }

        .stats-grid {
            max-width: 1200px;
            margin: 0 auto;
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 2rem;
        }

        .stat-box {
            text-align: center;
            padding: 2rem;
            background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
            border-radius: 20px;
        }

        .stat-number {
            font-size: 3.5rem;
            font-weight: 800;
            background: linear-gradient(135deg, #0ea5e9 0%, #06b6d4 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            margin-bottom: 0.5rem;
        }

        /* Interactive Timeline */
        .timeline {
            position: relative;
            padding: 2rem 0;
            margin: 3rem 0;
        }

        .timeline-item {
            position: relative;
            padding-left: 3rem;
            margin-bottom: 2rem;
            cursor: pointer;
            transition: all 0.3s;
        }

        .timeline-item::before {
            content: '';
            position: absolute;
            left: 0;
            top: 0;
            width: 16px;
            height: 16px;
            background: #0ea5e9;
            border-radius: 50%;
            border: 4px solid #e0f2fe;
        }

        .timeline-item::after {
            content: '';
            position: absolute;
            left: 7px;
            top: 16px;
            width: 2px;
            height: 100%;
            background: #e2e8f0;
        }

        .timeline-item:last-child::after {
            display: none;
        }

        .timeline-item:hover {
            transform: translateX(10px);
        }

        .timeline-content {
            background: white;
            padding: 1.5rem;
            border-radius: 12px;
            border: 2px solid #e2e8f0;
            transition: all 0.3s;
        }

        .timeline-item:hover .timeline-content {
            border-color: #0ea5e9;
            box-shadow: 0 8px 30px rgba(14, 165, 233, 0.15);
        }

        /* Search Bar */
        .search-container {
            max-width: 600px;
            margin: 2rem auto;
        }

        .search-bar {
            width: 100%;
            padding: 1.2rem 1.5rem;
            font-size: 1.1rem;
            border: 2px solid #e2e8f0;
            border-radius: 50px;
            transition: all 0.3s;
        }

        .search-bar:focus {
            outline: none;
            border-color: #0ea5e9;
            box-shadow: 0 0 0 4px rgba(14, 165, 233, 0.1);
        }

        /* Modal */
        .modal {
            display: none;
            position: fixed;
            top: 0;
            left: 0;
            width: 100%;
            height: 100%;
            background: rgba(0, 0, 0, 0.8);
            z-index: 2000;
            align-items: center;
            justify-content: center;
        }

        .modal.show {
            display: flex;
        }

        .modal-content {
            background: white;
            border-radius: 24px;
            padding: 3rem;
            max-width: 600px;
            width: 90%;
            position: relative;
            animation: slideUp 0.3s;
        }

        @keyframes slideUp {
            from { transform: translateY(50px); opacity: 0; }
            to { transform: translateY(0); opacity: 1; }
        }

        .modal-close {
            position: absolute;
            top: 1rem;
            right: 1rem;
            font-size: 2rem;
            cursor: pointer;
            color: #64748b;
            transition: color 0.3s;
        }

        .modal-close:hover {
            color: #0ea5e9;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .hero-content {
                grid-template-columns: 1fr;
            }
            
            .hero-text h1 {
                font-size: 2.5rem;
            }

            .nav-links {
                gap: 1rem;
                font-size: 0.9rem;
            }

            .card-grid {
                grid-template-columns: 1fr;
            }

            .tabs {
                flex-wrap: nowrap;
            }
        }
    </style>
</head>
<body>
    <!-- Navigation -->
    <nav>
        <div class="nav-container">
            <div class="logo" onclick="showPage('home')">ü´Å Breathe Life</div>
            <ul class="nav-links">
                <li><a onclick="showPage('home')" class="nav-link active" data-page="home">Home</a></li>
                <li><a onclick="showPage('about')" class="nav-link" data-page="about">About</a></li>
                <li><a onclick="showPage('prevention')" class="nav-link" data-page="prevention">Prevention</a></li>
                <li><a onclick="showPage('treatment')" class="nav-link" data-page="treatment">Treatment</a></li>
                <li><a onclick="showPage('resources')" class="nav-link" data-page="resources">Resources</a></li>
            </ul>
        </div>
    </nav>

    <!-- HOME PAGE -->
    <div id="home" class="page active">
        <section class="hero">
            <div class="hero-content">
                <div class="hero-text">
                    <h1>Every Breath Matters</h1>
                    <p style="font-size: 1.3rem; color: #475569; margin-bottom: 2rem;">Empowering lives through education, early detection, and comprehensive support in the fight against lung cancer.</p>
                    <button class="btn-primary" onclick="showPage('about')">Explore Resources ‚Üí</button>
                </div>
                <div>
                    <div style="background: white; border-radius: 24px; padding: 2rem; box-shadow: 0 20px 60px rgba(0,0,0,0.1);">
                        <h3 style="color: #0c4a6e; margin-bottom: 1.5rem; font-size: 1.5rem; text-align: center;">Global Impact 2025</h3>
                        <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 1rem;">
                            <div style="text-align: center; padding: 1.5rem; background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%); border-radius: 16px;">
                                <div style="font-size: 2.5rem; font-weight: 800; background: linear-gradient(135deg, #0ea5e9 0%, #06b6d4 100%); -webkit-background-clip: text; -webkit-text-fill-color: transparent;">2.5M</div>
                                <div style="color: #64748b; font-size: 0.9rem;">Annual Cases</div>
                            </div>
                            <div style="text-align: center; padding: 1.5rem; background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%); border-radius: 16px;">
                                <div style="font-size: 2.5rem; font-weight: 800; background: linear-gradient(135deg, #0ea5e9 0%, #06b6d4 100%); -webkit-background-clip: text; -webkit-text-fill-color: transparent;">63%</div>
                                <div style="color: #64748b; font-size: 0.9rem;">5-Year Survival</div>
                            </div>
                            <div style="text-align: center; padding: 1.5rem; background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%); border-radius: 16px;">
                                <div style="font-size: 2.5rem; font-weight: 800; background: linear-gradient(135deg, #0ea5e9 0%, #06b6d4 100%); -webkit-background-clip: text; -webkit-text-fill-color: transparent;">20%</div>
                                <div style="color: #64748b; font-size: 0.9rem;">Smoking Decline</div>
                            </div>
                            <div style="text-align: center; padding: 1.5rem; background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%); border-radius: 16px;">
                                <div style="font-size: 2.5rem; font-weight: 800; background: linear-gradient(135deg, #0ea5e9 0%, #06b6d4 100%); -webkit-background-clip: text; -webkit-text-fill-color: transparent;">75+</div>
                                <div style="color: #64748b; font-size: 0.9rem;">Countries</div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <!-- Animated Stats -->
        <section class="stats-section">
            <div class="stats-grid">
                <div class="stat-box">
                    <div class="stat-number" data-target="2500000">0</div>
                    <p style="color: #64748b; font-weight: 600;">New Cases Annually</p>
                </div>
                <div class="stat-box">
                    <div class="stat-number" data-target="63">0</div>
                    <p style="color: #64748b; font-weight: 600;">% Early Detection Survival</p>
                </div>
                <div class="stat-box">
                    <div class="stat-number" data-target="20">0</div>
                    <p style="color: #64748b; font-weight: 600;">% Decline in Smoking</p>
                </div>
                <div class="stat-box">
                    <div class="stat-number" data-target="1800000">0</div>
                    <p style="color: #64748b; font-weight: 600;">Deaths Prevented by Screening</p>
                </div>
            </div>
        </section>

        <!-- Testimonials Slider -->
        <section class="testimonials">
            <div class="testimonial-container">
                <div class="testimonial active">
                    <div class="testimonial-text">"Early detection saved my life. I'm now 5 years cancer-free and living every day to the fullest. Don't wait - get screened."</div>
                    <div class="testimonial-author">‚Äî Sarah M., Survivor</div>
                </div>
                <div class="testimonial">
                    <div class="testimonial-text">"The support I received made all the difference. I never felt alone during my treatment journey."</div>
                    <div class="testimonial-author">‚Äî James T., Survivor</div>
                </div>
                <div class="testimonial">
                    <div class="testimonial-text">"Knowledge is power. Understanding my diagnosis helped me make informed decisions about my care."</div>
                    <div class="testimonial-author">‚Äî Maria L., Survivor</div>
                </div>
                <div class="slider-controls">
                    <button class="slider-btn" onclick="changeTestimonial(-1)">‚Üê</button>
                    <button class="slider-btn" onclick="changeTestimonial(1)">‚Üí</button>
                </div>
            </div>
        </section>
    </div>

    <!-- ABOUT PAGE -->
    <div id="about" class="page">
        <div class="content-page">
            <div class="page-header">
                <h1>Understanding Lung Cancer</h1>
                <p style="font-size: 1.2rem; color: #64748b;">Comprehensive information about types, causes, symptoms, and diagnosis</p>
            </div>

            <!-- Search Bar -->
            <div class="search-container">
                <input type="text" class="search-bar" placeholder="üîç Search for symptoms, types, or information..." id="aboutSearch">
            </div>

            <!-- Tabs -->
            <div class="tabs">
                <button class="tab active" onclick="switchTab('basics')">Basics</button>
                <button class="tab" onclick="switchTab('types')">Types</button>
                <button class="tab" onclick="switchTab('symptoms')">Symptoms</button>
                <button class="tab" onclick="switchTab('diagnosis')">Diagnosis</button>
                <button class="tab" onclick="switchTab('stages')">Stages</button>
            </div>

            <!-- Tab Content: Basics -->
            <div id="basics" class="tab-content active">
                <div class="accordion">
                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>ü´Å What is Lung Cancer?</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p>Lung cancer occurs when cells in the lungs begin to grow abnormally and uncontrollably. These cancerous cells can form tumors that interfere with the lung's ability to provide oxygen to the bloodstream. It's the leading cause of cancer-related deaths worldwide, but when detected early, it's highly treatable.</p>
                            <p style="margin-top: 1rem;"><strong>Key Facts:</strong></p>
                            <ul style="margin-left: 1.5rem; margin-top: 0.5rem;">
                                <li>Most common cancer worldwide</li>
                                <li>Responsible for 1.8 million deaths annually</li>
                                <li>Early detection increases 5-year survival to 63%</li>
                                <li>Many cases are preventable</li>
                            </ul>
                        </div>
                    </div>

                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>üî¨ How Does It Develop?</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p>Lung cancer typically develops over many years. Repeated exposure to carcinogens (cancer-causing substances) damages the cells lining the lungs. Over time, these damaged cells can become cancerous.</p>
                            <p style="margin-top: 1rem;"><strong>Development Timeline:</strong></p>
                            <ul style="margin-left: 1.5rem; margin-top: 0.5rem;">
                                <li><strong>Years 0-10:</strong> Initial cell damage from carcinogens</li>
                                <li><strong>Years 10-20:</strong> Precancerous changes develop</li>
                                <li><strong>Years 20-30:</strong> Cancer may form and grow</li>
                                <li><strong>If untreated:</strong> Cancer can spread to other organs</li>
                            </ul>
                        </div>
                    </div>

                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>‚ö†Ô∏è Major Risk Factors</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p><strong>1. Smoking (Leading Cause):</strong> Responsible for 85-90% of lung cancer cases.</p>
                            <ul style="margin-left: 1.5rem; margin-top: 0.5rem;">
                                <li>9 out of 10 men with SCLC are smokers</li>
                                <li>8 out of 10 women with SCLC are smokers</li>
                                <li>Risk increases with number of cigarettes and years smoked</li>
                                <li>Cigars and pipe smoking also increase risk</li>
                            </ul>
                            <p style="margin-top: 1rem;"><strong>2. Secondhand Smoke:</strong> Increases risk by 20-30% in non-smokers. Regular exposure is dangerous even if you don't smoke.</p>
                            <p><strong>3. Radon Gas:</strong> Second leading cause. Radioactive gas from soil/rocks that can accumulate in homes. Test your home!</p>
                            <p><strong>4. Occupational Hazards:</strong></p>
                            <ul style="margin-left: 1.5rem; margin-top: 0.5rem;">
                                <li><strong>Asbestos:</strong> Found in older building materials</li>
                                <li>Coal tar, soot, industrial airborne pollutants</li>
                                <li>Exposure during renovation of older structures</li>
                                <li>Use protective equipment and follow safety regulations</li>
                            </ul>
                            <p><strong>5. Air Pollution:</strong> Long-term exposure to particulate matter and poor air quality.</p>
                            <p><strong>6. Family History:</strong> Genetic predisposition increases risk.</p>
                            <p style="margin-top: 1rem; padding: 1rem; background: #f0f9ff; border-radius: 8px;"><strong>üìä Impact:</strong> In the US, 57 per 100,000 people have lung cancer. SCLC represents 15-20% of all cases.</p>
                        </div>
                    </div>

                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>üìä Statistics & Prevalence</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p><strong>Global Impact:</strong></p>
                            <ul style="margin-left: 1.5rem;">
                                <li>2.5 million new cases diagnosed annually (2022 data)</li>
                                <li>1.8 million deaths per year worldwide</li>
                                <li>Most common cancer in men, second in women</li>
                                <li>Average age at diagnosis: 70 years</li>
                                <li>Rates declining in countries with tobacco control</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Tab Content: Types -->
            <div id="types" class="tab-content">
                <h3 style="color: #0c4a6e; font-size: 1.8rem; margin-bottom: 2rem;">Lung Cancer Classification</h3>
                
                <div class="card-grid">
                    <div class="interactive-card" onclick="openModal('nsclc')">
                        <div class="card-icon">üî¨</div>
                        <div class="card-title">Non-Small Cell (NSCLC)</div>
                        <p style="color: #64748b; margin-bottom: 0.5rem;"><strong>80-85%</strong> of all lung cancers</p>
                        <p style="color: #64748b; font-size: 0.9rem;">Grows slower, better prognosis</p>
                        <p style="color: #0ea5e9; font-weight: 600; margin-top: 1rem;">Click to learn more ‚Üí</p>
                    </div>

                    <div class="interactive-card" onclick="openModal('sclc')">
                        <div class="card-icon">‚ö°</div>
                        <div class="card-title">Small Cell (SCLC)</div>
                        <p style="color: #64748b; margin-bottom: 0.5rem;"><strong>15-20%</strong> of cases</p>
                        <p style="color: #64748b; font-size: 0.9rem;">Aggressive, fast-growing, neuroendocrine origin</p>
                        <p style="color: #0ea5e9; font-weight: 600; margin-top: 1rem;">Click to learn more ‚Üí</p>
                    </div>

                    <div class="interactive-card" onclick="openModal('rare')">
                        <div class="card-icon">üß¨</div>
                        <div class="card-title">Rare Types</div>
                        <p style="color: #64748b;">Carcinoid tumors, sarcomas, and other rare forms</p>
                        <p style="color: #0ea5e9; font-weight: 600; margin-top: 1rem;">Click to learn more ‚Üí</p>
                    </div>
                </div>

                <div style="background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%); padding: 2.5rem; border-radius: 20px; margin-top: 2rem;">
                    <h3 style="color: #0c4a6e; margin-bottom: 1.5rem; font-size: 1.5rem;">üìä NSCLC Subtypes (Most Common):</h3>
                    
                    <div style="display: grid; gap: 1.5rem;">
                        <div style="background: white; padding: 1.5rem; border-radius: 12px;">
                            <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">ü´Å Adenocarcinoma (40%)</h4>
                            <p style="color: #64748b; line-height: 1.8;">Most common type. Usually in outer lung regions. More common in non-smokers and women.</p>
                            <details style="margin-top: 1rem;">
                                <summary style="color: #0ea5e9; cursor: pointer; font-weight: 600;">Growth Patterns & Cell Origins ‚Üí</summary>
                                <div style="margin-top: 1rem; color: #64748b; line-height: 1.8;">
                                    <p><strong>Growth Patterns:</strong></p>
                                    <ul style="margin-left: 1.5rem; margin-top: 0.5rem;">
                                        <li><strong>Lepidic:</strong> Grows along alveolar walls, no invasion</li>
                                        <li><strong>Acinar:</strong> Forms tubules, resembles bronchial cells</li>
                                        <li><strong>Papillary:</strong> Finger-like projections with fibrovascular core</li>
                                        <li><strong>Micropapillary:</strong> Small tufts without fibrovascular core</li>
                                        <li><strong>Solid:</strong> Sheets of cells with mucin production</li>
                                    </ul>
                                    <p style="margin-top: 1rem;"><strong>Cells of Origin:</strong></p>
                                    <ul style="margin-left: 1.5rem;">
                                        <li><strong>Alveolar Type II (AT2) cells</strong> - primary origin</li>
                                        <li>Bronchioalveolar stem cells (BASCs)</li>
                                        <li>Club cells (especially in smokers)</li>
                                        <li>Basal cells and lineage-negative progenitors</li>
                                    </ul>
                                    <p style="margin-top: 1rem;"><strong>Common Mutations:</strong> KRAS (smokers), EGFR (non-smokers), ALK, BRAF, TP53, STK11</p>
                                </div>
                            </details>
                        </div>

                        <div style="background: white; padding: 1.5rem; border-radius: 12px;">
                            <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">üî∑ Squamous Cell Carcinoma (25-30%)</h4>
                            <p style="color: #64748b; line-height: 1.8;">Forms in central airways. Strongly linked to smoking. Large, polygonal cells with abundant cytoplasm and keratinization.</p>
                            <details style="margin-top: 1rem;">
                                <summary style="color: #0ea5e9; cursor: pointer; font-weight: 600;">Cell Origin & Mutations ‚Üí</summary>
                                <div style="margin-top: 1rem; color: #64748b; line-height: 1.8;">
                                    <p><strong>Origin:</strong> Basal cells lining the trachea and bronchi (express p63 and CK5). Sometimes from Club cells under chronic smoking injury.</p>
                                    <p style="margin-top: 1rem;"><strong>Key Mutations:</strong></p>
                                    <ul style="margin-left: 1.5rem;">
                                        <li><strong>3q26 amplification:</strong> SOX2, PIK3CA, TP63</li>
                                        <li><strong>TP53 mutations:</strong> ~65% of cases</li>
                                        <li><strong>PI3K pathway:</strong> PIK3CA, PTEN loss</li>
                                        <li><strong>FGFR1 amplification:</strong> ~20%</li>
                                        <li><strong>NRF2/KEAP1 alterations:</strong> Oxidative stress pathway</li>
                                    </ul>
                                </div>
                            </details>
                        </div>

                        <div style="background: white; padding: 1.5rem; border-radius: 12px;">
                            <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">üî∂ Large Cell Carcinoma (10-15%)</h4>
                            <p style="color: #64748b; line-height: 1.8;">Undifferentiated cancer lacking features of other types. No gland formation, keratinization, or small cell characteristics.</p>
                            <details style="margin-top: 1rem;">
                                <summary style="color: #0ea5e9; cursor: pointer; font-weight: 600;">Characteristics & Mutations ‚Üí</summary>
                                <div style="margin-top: 1rem; color: #64748b; line-height: 1.8;">
                                    <p><strong>About 37% have targetable drivers:</strong></p>
                                    <ul style="margin-left: 1.5rem;">
                                        <li><strong>KRAS:</strong> ~30% (most frequent)</li>
                                        <li>Rare: EGFR, BRAF, MEK1, ALK, PIK3CA</li>
                                        <li><strong>Marker-null LCC:</strong> TP53 (~94%), RB1 (~31%), KEAP1 (~25%)</li>
                                    </ul>
                                </div>
                            </details>
                        </div>
                    </div>
                </div>

                <div style="background: linear-gradient(135deg, #fef2f2 0%, #fee2e2 100%); padding: 2.5rem; border-radius: 20px; margin-top: 2rem;">
                    <h3 style="color: #991b1b; margin-bottom: 1.5rem; font-size: 1.5rem;">‚ö° Small Cell Lung Cancer (SCLC) - Detailed</h3>
                    <p style="color: #64748b; line-height: 1.8; margin-bottom: 1.5rem;">High-grade neuroendocrine carcinoma. Extremely aggressive with poor prognosis. Originates from neuroendocrine cells in the bronchi.</p>
                    
                    <div style="background: white; padding: 2rem; border-radius: 12px; margin-bottom: 1.5rem;">
                        <h4 style="color: #0c4a6e; margin-bottom: 1rem;">Cellular Characteristics:</h4>
                        <ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;">
                            <li>Very small round-to-fusiform cells</li>
                            <li>Extremely high nucleus-to-cytoplasm ratio</li>
                            <li>"Salt and pepper" chromatin (finely granular)</li>
                            <li>Inconspicuous nucleoli with nuclear molding</li>
                            <li>Very high mitotic rate and extensive necrosis</li>
                            <li>Often arranged in sheets or clusters</li>
                        </ul>
                        
                        <h4 style="color: #0c4a6e; margin: 1.5rem 0 1rem;">Two Subtypes:</h4>
                        <ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;">
                            <li><strong>Small Cell Carcinoma:</strong> Most common type</li>
                            <li><strong>Combined Small Cell Carcinoma:</strong> Mix of SCLC + NSCLC (rare)</li>
                        </ul>

                        <h4 style="color: #0c4a6e; margin: 1.5rem 0 1rem;">‚ö†Ô∏è Special Complications:</h4>
                        <ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;">
                            <li>Progresses and metastasizes very quickly</li>
                            <li>Can cause fluid buildup in lungs (squeezes air out)</li>
                            <li><strong>Paraneoplastic syndromes:</strong> SIADH, Cushing's syndrome, Lambert-Eaton syndrome</li>
                            <li>Early spread to lymph nodes, bones, brain, liver, adrenal glands</li>
                        </ul>
                    </div>

                    <div style="background: white; padding: 2rem; border-radius: 12px; margin-bottom: 1.5rem;">
                        <h4 style="color: #0c4a6e; margin-bottom: 1rem;">üß¨ Cell Origin - New Research Findings:</h4>
                        <div style="background: #f0f9ff; padding: 1.5rem; border-radius: 8px; margin-bottom: 1rem;">
                            <p style="color: #64748b; line-height: 1.8;"><strong>Traditional View:</strong> Previously believed to originate from pulmonary neuroendocrine cells (PNEC), especially for SCLC-A (ASCL1+) and SCLC-N (NEUROD1+) subtypes.</p>
                        </div>
                        <div style="background: #ecfdf5; padding: 1.5rem; border-radius: 8px;">
                            <p style="color: #64748b; line-height: 1.8;"><strong>New Discovery:</strong> Recent findings suggest <strong>lung basal cells</strong> as the origin, especially for tuft-like SCLC-P tumors. This changes our understanding of SCLC development.</p>
                        </div>
                    </div>

                    <div style="background: white; padding: 2rem; border-radius: 12px;">
                        <h4 style="color: #0c4a6e; margin-bottom: 1.5rem;">üî¨ Four Molecular Subtypes of SCLC:</h4>
                        
                        <details style="margin-bottom: 1rem; border: 2px solid #e0f2fe; border-radius: 8px; padding: 1rem;">
                            <summary style="color: #0ea5e9; font-weight: 700; cursor: pointer; font-size: 1.1rem;">SCLC-A (ASCL1+) - Classic Neuroendocrine ‚Üí</summary>
                            <div style="margin-top: 1rem; color: #64748b; line-height: 1.8;">
                                <p><strong>Primary Marker:</strong> ASCL1+</p>
                                <p><strong>Cell Origin:</strong> PNEC or Basal cells</p>
                                <p><strong>Genetics:</strong> RB1/TP53 loss, MYCL activation</p>
                                <p><strong>Characteristics:</strong> Neuroendocrine-high, classic SCLC phenotype. Most common subtype.</p>
                            </div>
                        </details>

                        <details style="margin-bottom: 1rem; border: 2px solid #e0f2fe; border-radius: 8px; padding: 1rem;">
                            <summary style="color: #0ea5e9; font-weight: 700; cursor: pointer; font-size: 1.1rem;">SCLC-N (NEUROD1+) - Neuronal Features ‚Üí</summary>
                            <div style="margin-top: 1rem; color: #64748b; line-height: 1.8;">
                                <p><strong>Primary Marker:</strong> NEUROD1+</p>
                                <p><strong>Cell Origin:</strong> PNEC or Basal cells</p>
                                <p><strong>Genetics:</strong> RB1/TP53 loss, variable MYC</p>
                                <p><strong>Characteristics:</strong> Neuronal features, neuroendocrine-high phenotype.</p>
                            </div>
                        </details>

                        <details style="margin-bottom: 1rem; border: 2px solid #fecaca; border-radius: 8px; padding: 1rem;">
                            <summary style="color: #ef4444; font-weight: 700; cursor: pointer; font-size: 1.1rem;">SCLC-P (POU2F3+) - Tuft-like, WORST PROGNOSIS ‚ö†Ô∏è ‚Üí</summary>
                            <div style="margin-top: 1rem; color: #64748b; line-height: 1.8;">
                                <p><strong>Primary Marker:</strong> POU2F3+ (tuft-like)</p>
                                <p><strong>Cell Origin:</strong> Basal cells</p>
                                <p><strong>Genetics:</strong> RB1/TP53 loss, MYC amplification (56%), PTEN loss (63%)</p>
                                <p style="color: #ef4444; font-weight: 600; background: #fee2e2; padding: 0.5rem; border-radius: 4px; margin-top: 0.5rem;"><strong>‚ö†Ô∏è WARNING:</strong> Most aggressive subtype with worst prognosis. Non-neuroendocrine phenotype.</p>
                            </div>
                        </details>

                        <details style="margin-bottom: 1rem; border: 2px solid #e0f2fe; border-radius: 8px; padding: 1rem;">
                            <summary style="color: #0ea5e9; font-weight: 700; cursor: pointer; font-size: 1.1rem;">SCLC-Y (YAP1+) - Inflammatory/Basal-like ‚Üí</summary>
                            <div style="margin-top: 1rem; color: #64748b; line-height: 1.8;">
                                <p><strong>Primary Marker:</strong> YAP1+</p>
                                <p><strong>Cell Origin:</strong> Basal-like cells</p>
                                <p><strong>Genetics:</strong> Variable</p>
                                <p><strong>Characteristics:</strong> Inflammatory features, basal-like phenotype.</p>
                            </div>
                        </details>
                    </div>

                    <div style="background: white; padding: 2rem; border-radius: 12px; margin-top: 1.5rem;">
                        <h4 style="color: #0c4a6e; margin-bottom: 1.5rem;">üß¨ Key Gene Mutations in SCLC:</h4>
                        
                        <div style="overflow-x: auto;">
                            <table style="width: 100%; border-collapse: collapse; color: #64748b; font-size: 0.9rem;">
                                <thead>
                                    <tr style="background: #f0f9ff;">
                                        <th style="padding: 0.75rem; text-align: left; border: 1px solid #e2e8f0;">Gene</th>
                                        <th style="padding: 0.75rem; text-align: left; border: 1px solid #e2e8f0;">Type</th>
                                        <th style="padding: 0.75rem; text-align: left; border: 1px solid #e2e8f0;">Frequency</th>
                                        <th style="padding: 0.75rem; text-align: left; border: 1px solid #e2e8f0;">Function</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr style="background: #fef2f2;">
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>RB1</strong></td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Tumor Suppressor</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>Nearly universal loss</strong></td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Cell cycle regulation</td>
                                    </tr>
                                    <tr style="background: #fef2f2;">
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>TP53</strong></td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Tumor Suppressor</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>Nearly universal loss</strong></td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">DNA damage response</td>
                                    </tr>
                                    <tr>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>MYCL</strong></td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Oncogene</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">NE-high subtypes</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Transcriptional activation</td>
                                    </tr>
                                    <tr>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>MYC</strong></td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Oncogene</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">56% SCLC-P; 19% SCLC-low</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Promotes subtype diversity</td>
                                    </tr>
                                    <tr style="background: #f0f9ff;">
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>ASCL1</strong></td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Transcription Factor</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">SCLC-A defining</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Neuroendocrine differentiation</td>
                                    </tr>
                                    <tr style="background: #fee2e2;">
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>POU2F3</strong></td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Oncogene/TF</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">SCLC-P defining</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>Tuft-like fate, MOST AGGRESSIVE</strong></td>
                                    </tr>
                                    <tr style="background: #f0f9ff;">
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>NEUROD1</strong></td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Transcription Factor</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">SCLC-N defining</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Neuronal differentiation</td>
                                    </tr>
                                    <tr>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>YAP1</strong></td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Transcription Factor</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">SCLC-Y defining</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Basal-like/inflammatory</td>
                                    </tr>
                                    <tr style="background: #fef2f2;">
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>ATOH1</strong></td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Transcription Factor</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Aggressive</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Pro-metastatic, inner ear signatures</td>
                                    </tr>
                                    <tr>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;"><strong>PTEN</strong></td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">Tumor Suppressor</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">63% SCLC-P; 27% SCLC-low</td>
                                        <td style="padding: 0.75rem; border: 1px solid #e2e8f0;">PI3K/AKT pathway regulation</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <div style="background: #fef9e7; border-left: 4px solid #f59e0b; padding: 1.5rem; border-radius: 8px; margin-top: 1.5rem;">
                            <h5 style="color: #92400e; margin-bottom: 0.5rem;">üí° Clinical Significance:</h5>
                            <p style="color: #64748b; line-height: 1.8;">Understanding SCLC subtypes is crucial for prognosis and treatment planning. SCLC-P patients have the worst outcomes and may need more aggressive treatment strategies. RB1 and TP53 loss are hallmarks of all SCLC, making them potential therapeutic targets for future treatments.</p>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Tab Content: Symptoms -->
            <div id="symptoms" class="tab-content">
                <h3 style="color: #0c4a6e; font-size: 2rem; margin-bottom: 2rem;">Recognizing the Warning Signs</h3>
                
                <div class="timeline">
                    <div class="timeline-item">
                        <div class="timeline-content">
                            <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">Early Symptoms (Often Subtle)</h4>
                            <ul style="color: #64748b; margin-left: 1.5rem; margin-top: 0.5rem;">
                                <li>Persistent cough lasting more than 2-3 weeks</li>
                                <li>Changes in existing chronic cough</li>
                                <li>Shortness of breath during normal activities</li>
                                <li>Chest discomfort or mild pain</li>
                            </ul>
                        </div>
                    </div>

                    <div class="timeline-item">
                        <div class="timeline-content">
                            <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">Progressive Symptoms</h4>
                            <ul style="color: #64748b; margin-left: 1.5rem; margin-top: 0.5rem;">
                                <li>Coughing up blood (hemoptysis)</li>
                                <li>Hoarseness or voice changes</li>
                                <li>Recurring lung infections (pneumonia, bronchitis)</li>
                                <li>Wheezing or noisy breathing</li>
                            </ul>
                        </div>
                    </div>

                    <div class="timeline-item">
                        <div class="timeline-content">
                            <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">Advanced Symptoms</h4>
                            <ul style="color: #64748b; margin-left: 1.5rem; margin-top: 0.5rem;">
                                <li>Unexplained weight loss (10+ pounds)</li>
                                <li>Severe fatigue and weakness</li>
                                <li>Bone pain (if spread to bones)</li>
                                <li>Headaches (if spread to brain)</li>
                                <li>Swelling in face or neck</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <div style="background: #fef2f2; border-left: 4px solid #ef4444; padding: 2rem; border-radius: 12px; margin-top: 2rem;">
                    <h4 style="color: #991b1b; margin-bottom: 1rem;">‚ö†Ô∏è When to See a Doctor Immediately</h4>
                    <p style="color: #64748b;">Contact your healthcare provider if you experience:</p>
                    <ul style="color: #64748b; margin-left: 1.5rem; margin-top: 0.5rem;">
                        <li>Coughing up blood</li>
                        <li>Severe chest pain</li>
                        <li>Extreme shortness of breath</li>
                        <li>Sudden weight loss with no explanation</li>
                    </ul>
                </div>
            </div>

            <!-- Tab Content: Diagnosis -->
            <div id="diagnosis" class="tab-content">
                <h3 style="color: #0c4a6e; font-size: 2rem; margin-bottom: 2rem;">Comprehensive Diagnostic Process</h3>
                
                <div class="timeline">
                    <div class="timeline-item">
                        <div class="timeline-content">
                            <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">Step 1: Preliminary Evaluation</h4>
                            <ul style="color: #64748b; margin-left: 1.5rem; margin-top: 0.5rem; line-height: 1.8;">
                                <li>Comprehensive patient history (smoking, symptoms, family history)</li>
                                <li>Physical examination</li>
                                <li>Laboratory tests: CBC, liver/kidney function, electrolytes</li>
                                <li>Check for paraneoplastic syndromes (low sodium/SIADH in SCLC)</li>
                            </ul>
                        </div>
                    </div>

                    <div class="timeline-item">
                        <div class="timeline-content">
                            <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">Step 2: Imaging Studies</h4>
                            <ul style="color: #64748b; margin-left: 1.5rem; margin-top: 0.5rem; line-height: 1.8;">
                                <li><strong>Chest X-ray:</strong> Initial screening</li>
                                <li><strong>CT Chest & Abdomen:</strong> Essential for tumor identification, lymph nodes, metastases</li>
                                <li><strong>Brain Imaging:</strong> MRI preferred for SCLC; CT with contrast if MRI unavailable</li>
                                <li><strong>PET/CT:</strong> Particularly for NSCLC staging</li>
                            </ul>
                        </div>
                    </div>

                    <div class="timeline-item">
                        <div class="timeline-content">
                            <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">Step 3: Tissue Diagnosis</h4>
                            <p style="color: #64748b; margin-bottom: 0.5rem;">Obtaining tissue/cells for analysis:</p>
                            <ul style="color: #64748b; margin-left: 1.5rem; line-height: 1.8;">
                                <li><strong>Bronchoscopy with biopsy</strong></li>
                                <li><strong>Endobronchial ultrasound (EBUS)</strong></li>
                                <li><strong>CT-guided needle biopsy</strong></li>
                                <li><strong>Thoracentesis:</strong> If pleural effusion present</li>
                            </ul>
                        </div>
                    </div>

                    <div class="timeline-item">
                        <div class="timeline-content">
                            <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">Step 4: Pathology Analysis</h4>
                            <div style="background: #f0f9ff; padding: 1rem; border-radius: 8px; margin-top: 0.5rem;">
                                <p style="color: #64748b; line-height: 1.8; margin-bottom: 1rem;"><strong>SCLC Characteristics:</strong></p>
                                <ul style="color: #64748b; margin-left: 1.5rem; line-height: 1.8;">
                                    <li>Small, round-to-oval cells</li>
                                    <li>High mitotic index (rapid division)</li>
                                    <li>"Salt and pepper" chromatin pattern</li>
                                    <li>Neuroendocrine markers positive</li>
                                </ul>
                                
                                <p style="color: #64748b; line-height: 1.8; margin: 1rem 0;"><strong>NSCLC Classification:</strong></p>
                                <ul style="color: #64748b; margin-left: 1.5rem; line-height: 1.8;">
                                    <li>Subtype identification: Adenocarcinoma, Squamous, Large Cell</li>
                                    <li>Histology and immunohistochemistry used</li>
                                    <li>Growth pattern analysis for adenocarcinoma</li>
                                </ul>
                            </div>
                        </div>
                    </div>

                    <div class="timeline-item">
                        <div class="timeline-content">
                            <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">Step 5: Molecular Testing (NSCLC)</h4>
                            <p style="color: #64748b; margin-bottom: 0.5rem;">Critical for treatment planning:</p>
                            <ul style="color: #64748b; margin-left: 1.5rem; line-height: 1.8;">
                                <li><strong>EGFR mutations</strong> (targeted therapy available)</li>
                                <li><strong>ALK rearrangements</strong></li>
                                <li><strong>ROS1, BRAF, KRAS G12C</strong></li>
                                <li><strong>PD-L1 expression</strong> (immunotherapy eligibility)</li>
                                <li>Other biomarkers: MET, RET, NTRK</li>
                            </ul>
                        </div>
                    </div>

                    <div class="timeline-item">
                        <div class="timeline-content">
                            <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">Step 6: Staging</h4>
                            <p style="color: #64748b;">Determines extent of cancer spread (Stage I-IV) to guide treatment decisions.</p>
                        </div>
                    </div>
                </div>

                <div style="background: linear-gradient(135deg, #fef2f2 0%, #fee2e2 100%); padding: 2rem; border-radius: 12px; margin-top: 2rem;">
                    <h4 style="color: #991b1b; margin-bottom: 1rem;">üî¨ Key Diagnostic Differences: SCLC vs NSCLC</h4>
                    <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 1.5rem;">
                        <div style="background: white; padding: 1.5rem; border-radius: 12px;">
                            <h5 style="color: #0c4a6e; margin-bottom: 0.5rem;">SCLC Features</h5>
                            <ul style="color: #64748b; margin-left: 1.5rem; font-size: 0.9rem; line-height: 1.8;">
                                <li>Progresses faster</li>
                                <li>Metastasizes earlier</li>
                                <li>Paraneoplastic syndromes common</li>
                                <li>Brain imaging essential</li>
                                <li>Limited vs Extensive staging</li>
                            </ul>
                        </div>
                        <div style="background: white; padding: 1.5rem; border-radius: 12px;">
                            <h5 style="color: #0c4a6e; margin-bottom: 0.5rem;">NSCLC Features</h5>
                            <ul style="color: #64748b; margin-left: 1.5rem; font-size: 0.9rem; line-height: 1.8;">
                                <li>Grows more slowly</li>
                                <li>Often found incidentally</li>
                                <li>Molecular testing crucial</li>
                                <li>Stage I-IV classification</li>
                                <li>Targetable mutations common</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Tab Content: Stages -->
            <div id="stages" class="tab-content">
                <h3 style="color: #0c4a6e; font-size: 2rem; margin-bottom: 2rem;">Cancer Stages Explained</h3>
                
                <div class="accordion">
                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>Stage I: Early, Localized Cancer</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p><strong>Description:</strong> Cancer is small and contained within the lung. Has not spread to lymph nodes.</p>
                            <p><strong>5-Year Survival Rate:</strong> 60-70% with treatment</p>
                            <p><strong>Treatment:</strong> Surgery is often curative. May follow with chemotherapy.</p>
                            <p><strong>Size:</strong> Tumor ‚â§3cm (Stage IA) or 3-4cm (Stage IB)</p>
                        </div>
                    </div>

                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>Stage II: Larger or Spreading to Nearby Nodes</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p><strong>Description:</strong> Tumor is larger or has spread to nearby lymph nodes.</p>
                            <p><strong>5-Year Survival Rate:</strong> 40-50%</p>
                            <p><strong>Treatment:</strong> Surgery + chemotherapy. Sometimes radiation.</p>
                            <p><strong>Size:</strong> Tumor 4-5cm or spread to nearby lymph nodes</p>
                        </div>
                    </div>

                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>Stage III: Advanced Local Spread</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p><strong>Description:</strong> Cancer has spread extensively to lymph nodes or nearby structures.</p>
                            <p><strong>5-Year Survival Rate:</strong> 15-30%</p>
                            <p><strong>Treatment:</strong> Combination of chemotherapy, radiation, possibly surgery or immunotherapy.</p>
                            <p><strong>Note:</strong> Often not operable, but treatment can extend life significantly.</p>
                        </div>
                    </div>

                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>Stage IV: Metastatic (Spread to Distant Sites)</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p><strong>Description:</strong> Cancer has spread to other organs (brain, bones, liver, other lung).</p>
                            <p><strong>5-Year Survival Rate:</strong> 5-10%, but improving with new treatments</p>
                            <p><strong>Treatment:</strong> Targeted therapy, immunotherapy, chemotherapy, radiation for symptom relief.</p>
                            <p><strong>Hope:</strong> New treatments offering longer survival and better quality of life.</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- PREVENTION PAGE -->
    <div id="prevention" class="page">
        <div class="content-page">
            <div class="page-header">
                <h1>Prevention & Risk Reduction</h1>
                <p style="font-size: 1.2rem; color: #64748b;">Take control of your lung health with proven strategies</p>
            </div>

            <!-- Risk Calculator -->
            <div class="calculator">
                <h3>üéØ Assess Your Risk Level</h3>
                <p style="text-align: center; color: #64748b; margin-bottom: 2rem;">Answer these questions to get a personalized risk assessment</p>
                
                <div class="question">
                    <label>Do you currently smoke?</label>
                    <select id="smoking">
                        <option value="0">Never smoked</option>
                        <option value="3">Former smoker (quit &gt;10 years ago)</option>
                        <option value="5">Former smoker (quit &lt;10 years ago)</option>
                        <option value="8">Current smoker (&lt;1 pack/day)</option>
                        <option value="10">Current smoker (‚â•1 pack/day)</option>
                    </select>
                </div>

                <div class="question">
                    <label>Your age:</label>
                    <select id="age">
                        <option value="0">Under 40</option>
                        <option value="2">40-54</option>
                        <option value="5">55-64</option>
                        <option value="7">65-74</option>
                        <option value="8">75+</option>
                    </select>
                </div>

                <div class="question">
                    <label>Exposure to secondhand smoke:</label>
                    <select id="secondhand">
                        <option value="0">Rarely or never</option>
                        <option value="2">Occasional</option>
                        <option value="4">Frequent (home or work)</option>
                    </select>
                </div>

                <div class="question">
                    <label>Family history of lung cancer:</label>
                    <select id="family">
                        <option value="0">No family history</option>
                        <option value="3">One relative</option>
                        <option value="5">Multiple relatives</option>
                    </select>
                </div>

                <div class="question">
                    <label>Occupational exposure (asbestos, chemicals):</label>
                    <select id="occupational">
                        <option value="0">No exposure</option>
                        <option value="3">Past exposure</option>
                        <option value="5">Current exposure</option>
                    </select>
                </div>

                <button class="btn-primary" onclick="calculateRisk()" style="width: 100%; margin-top: 1rem;">Calculate My Risk</button>

                <div class="risk-result" id="riskResult">
                    <h4 style="color: #0c4a6e; margin-bottom: 1rem;">Your Risk Level:</h4>
                    <div class="risk-level" id="riskLevel"></div>
                    <p id="riskAdvice" style="color: #64748b; margin-top: 1rem; line-height: 1.8;"></p>
                </div>
            </div>

            <!-- Prevention Strategies -->
            <h3 style="color: #0c4a6e; font-size: 2rem; margin: 3rem 0 2rem;">Proven Prevention Strategies</h3>
            
            <div class="card-grid">
                <div class="interactive-card">
                    <div class="card-icon">üö≠</div>
                    <div class="card-title">Quit Smoking</div>
                    <p style="color: #64748b; margin-bottom: 1rem;">The #1 way to prevent lung cancer. Risk drops 50% within 10 years. Smoking causes 85-90% of all lung cancer cases.</p>
                    <div style="background: #f0f9ff; padding: 1rem; border-radius: 8px; margin-top: 1rem;">
                        <strong style="color: #0c4a6e;">Recursos en Espa√±a:</strong>
                        <ul style="color: #64748b; margin-left: 1.5rem; margin-top: 0.5rem; font-size: 0.9rem;">
                            <li>900 850 300 - L√≠nea para dejar de fumar</li>
                            <li>Terapia de reemplazo de nicotina</li>
                            <li>Medicamentos con receta (vareniclina, bupropi√≥n)</li>
                            <li>Grupos de apoyo AECC</li>
                            <li>Asesoramiento psicol√≥gico</li>
                        </ul>
                        <p style="color: #64748b; margin-top: 0.5rem; font-size: 0.9rem;"><strong>Beneficios:</strong> Dejar de fumar puede reducir el da√±o pulmonar antes de que se desarrolle el c√°ncer. ¬°Nunca es tarde!</p>
                    </div>
                </div>

                <div class="interactive-card">
                    <div class="card-icon">üè†</div>
                    <div class="card-title">Test for Radon</div>
                    <p style="color: #64748b;">Second leading cause of lung cancer. Radioactive gas from soil/rocks. Simple home test kits $20-30.</p>
                    <div class="progress-bar" style="margin-top: 1rem;">
                        <div class="progress-fill" style="width: 60%;"></div>
                    </div>
                    <p style="color: #64748b; font-size: 0.9rem; margin-top: 0.5rem;">60% of homes have safe radon levels</p>
                    <p style="color: #64748b; font-size: 0.9rem; margin-top: 0.5rem;"><strong>Espa√±a:</strong> El rad√≥n es com√∫n en Galicia, Castilla y Le√≥n, Madrid y Extremadura. ¬°Prueba tu hogar!</p>
                </div>

                <div class="interactive-card">
                    <div class="card-icon">üò∑</div>
                    <div class="card-title">Avoid Carcinogens</div>
                    <p style="color: #64748b; margin-bottom: 1rem;">Protect from harmful workplace and environmental chemicals.</p>
                    <ul style="color: #64748b; margin-left: 1.5rem; font-size: 0.9rem; line-height: 1.8;">
                        <li><strong>Asbestos:</strong> Older building materials, insulation</li>
                        <li><strong>Coal tar, soot:</strong> Industrial pollutants</li>
                        <li>Use protective equipment at work</li>
                        <li>Follow safety regulations</li>
                        <li>Avoid renovation of old structures without protection</li>
                    </ul>
                </div>

                <div class="interactive-card">
                    <div class="card-icon">ü•ó</div>
                    <div class="card-title">Healthy Diet & Exercise</div>
                    <p style="color: #64748b;">Strengthen your body's natural defenses.</p>
                    <ul style="color: #64748b; margin-left: 1.5rem; font-size: 0.9rem; line-height: 1.8; margin-top: 0.5rem;">
                        <li>Eat fruits and vegetables (antioxidants)</li>
                        <li>Exercise 30 minutes daily</li>
                        <li>Maintain healthy weight</li>
                        <li>Limit alcohol intake</li>
                    </ul>
                </div>

                <div class="interactive-card">
                    <div class="card-icon">üîç</div>
                    <div class="card-title">Get Screened</div>
                    <p style="color: #64748b;">Annual low-dose CT for high-risk adults 55-80. Early detection saves lives - 63% 5-year survival when caught early.</p>
                    <p style="color: #64748b; font-size: 0.9rem; margin-top: 0.5rem;"><strong>Espa√±a:</strong> Consulta con tu m√©dico si eres fumador/ex-fumador de larga duraci√≥n.</p>
                </div>

                <div class="interactive-card">
                    <div class="card-icon">üå¨Ô∏è</div>
                    <div class="card-title">Air Quality</div>
                    <p style="color: #64748b;">Reduce exposure to air pollution:</p>
                    <ul style="color: #64748b; margin-left: 1.5rem; font-size: 0.9rem; line-height: 1.8; margin-top: 0.5rem;">
                        <li>Check air quality index daily</li>
                        <li>Stay indoors on bad air days</li>
                        <li>Use HEPA air filters at home</li>
                        <li>Support clean air policies</li>
                        <li>Avoid heavy traffic areas when possible</li>
                    </ul>
                </div>
            </div>

            <div style="background: linear-gradient(135deg, #fef2f2 0%, #fee2e2 100%); padding: 2.5rem; border-radius: 20px; margin-top: 2rem;">
                <h3 style="color: #991b1b; margin-bottom: 1.5rem; font-size: 1.8rem;">‚ö†Ô∏è Critical: Both NSCLC & SCLC Share Same Risk Factors</h3>
                <p style="color: #64748b; line-height: 1.8; margin-bottom: 1rem;">The same factors that cause Non-Small Cell Lung Cancer also cause Small Cell Lung Cancer. Prevention strategies work for both types!</p>
                
                <div style="background: white; padding: 2rem; border-radius: 12px;">
                    <h4 style="color: #0c4a6e; margin-bottom: 1rem;">üìä Prevention Impact Statistics:</h4>
                    <ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;">
                        <li><strong>Quitting smoking:</strong> Reduces lung cancer risk by 30-50% after 10 years</li>
                        <li><strong>Avoiding secondhand smoke:</strong> Reduces risk by 20-30%</li>
                        <li><strong>Radon mitigation:</strong> Can reduce risk by 50% in high-radon homes</li>
                        <li><strong>Screening high-risk individuals:</strong> Reduces lung cancer deaths by 20%</li>
                        <li><strong>Healthy lifestyle:</strong> Combined diet + exercise may reduce risk by 25-30%</li>
                    </ul>
                </div>
            </div>
        </div>
    </div>

    <!-- TREATMENT PAGE -->
    <div id="treatment" class="page">
        <div class="content-page">
            <div class="page-header">
                <h1>Treatment Options</h1>
                <p style="font-size: 1.2rem; color: #64748b;">Modern, personalized approaches to fighting lung cancer</p>
            </div>

            <!-- Tabs for Treatment -->
            <div class="tabs">
                <button class="tab active" onclick="switchTab('surgery-tab')">Surgery</button>
                <button class="tab" onclick="switchTab('chemo-tab')">Chemotherapy</button>
                <button class="tab" onclick="switchTab('radiation-tab')">Radiation</button>
                <button class="tab" onclick="switchTab('targeted-tab')">Targeted Therapy</button>
                <button class="tab" onclick="switchTab('immuno-tab')">Immunotherapy</button>
            </div>

            <!-- Surgery Tab -->
            <div id="surgery-tab" class="tab-content active">
                <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 2rem; margin-top: 2rem;">
                    <div>
                        <h3 style="color: #0c4a6e; font-size: 1.8rem; margin-bottom: 1rem;">üî™ Surgical Options</h3>
                        <p style="color: #64748b; line-height: 1.8; margin-bottom: 2rem;">Surgery is most effective for early-stage lung cancer. The goal is to remove the tumor and surrounding tissue.</p>
                        
                        <div class="accordion">
                            <div class="accordion-item">
                                <div class="accordion-header" onclick="toggleAccordion(this)">
                                    <span>Lobectomy (Most Common)</span>
                                    <span class="accordion-icon">‚ñº</span>
                                </div>
                                <div class="accordion-content">
                                    <p>Removal of an entire lobe of the lung. The lung has 5 lobes (3 right, 2 left).</p>
                                    <p><strong>Best for:</strong> Early-stage tumors contained in one lobe</p>
                                    <p><strong>Recovery:</strong> 4-6 weeks</p>
                                    <p><strong>Outcome:</strong> Highest cure rate for early cancer</p>
                                </div>
                            </div>

                            <div class="accordion-item">
                                <div class="accordion-header" onclick="toggleAccordion(this)">
                                    <span>Wedge/Segmental Resection</span>
                                    <span class="accordion-icon">‚ñº</span>
                                </div>
                                <div class="accordion-content">
                                    <p>Removal of small section of lung with tumor.</p>
                                    <p><strong>Best for:</strong> Very small tumors, patients with poor lung function</p>
                                    <p><strong>Recovery:</strong> 2-4 weeks</p>
                                </div>
                            </div>

                            <div class="accordion-item">
                                <div class="accordion-header" onclick="toggleAccordion(this)">
                                    <span>Pneumonectomy</span>
                                    <span class="accordion-icon">‚ñº</span>
                                </div>
                                <div class="accordion-content">
                                    <p>Removal of entire lung. Reserved for large tumors.</p>
                                    <p><strong>Recovery:</strong> 6-8 weeks</p>
                                    <p><strong>Note:</strong> Can live normally with one lung</p>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div>
                        <div style="background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%); padding: 2rem; border-radius: 20px; height: fit-content;">
                            <h4 style="color: #0c4a6e; margin-bottom: 1rem;">‚úÖ Surgery Success Rates</h4>
                            <div style="margin-bottom: 1.5rem;">
                                <p style="color: #64748b; margin-bottom: 0.5rem;"><strong>Stage I:</strong></p>
                                <div class="progress-bar">
                                    <div class="progress-fill" style="width: 70%;"></div>
                                </div>
                                <p style="color: #64748b; font-size: 0.9rem;">70% 5-year survival</p>
                            </div>

                            <div style="margin-bottom: 1.5rem;">
                                <p style="color: #64748b; margin-bottom: 0.5rem;"><strong>Stage II:</strong></p>
                                <div class="progress-bar">
                                    <div class="progress-fill" style="width: 50%;"></div>
                                </div>
                                <p style="color: #64748b; font-size: 0.9rem;">50% 5-year survival</p>
                            </div>

                            <h4 style="color: #0c4a6e; margin: 2rem 0 1rem;">Minimally Invasive Options</h4>
                            <ul style="color: #64748b; margin-left: 1.5rem; line-height: 1.8;">
                                <li><strong>VATS:</strong> Video-assisted thoracic surgery</li>
                                <li><strong>Robot-assisted:</strong> Greater precision</li>
                                <li>Smaller incisions, faster recovery</li>
                                <li>Less pain, shorter hospital stay</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Chemotherapy Tab -->
            <div id="chemo-tab" class="tab-content">
                <h3 style="color: #0c4a6e; font-size: 2rem; margin-bottom: 2rem;">üíâ Chemotherapy: Systemic Treatment</h3>
                
                <div class="card-grid">
                    <div class="interactive-card">
                        <div class="card-icon">üéØ</div>
                        <div class="card-title">How It Works</div>
                        <p style="color: #64748b;">Powerful drugs that kill rapidly dividing cells throughout the body. Usually given in cycles with rest periods.</p>
                    </div>

                    <div class="interactive-card">
                        <div class="card-icon">‚è±Ô∏è</div>
                        <div class="card-title">Treatment Schedule</div>
                        <p style="color: #64748b;">Typical: 3-4 cycles, each 3-4 weeks long. Total duration: 3-6 months.</p>
                    </div>

                    <div class="interactive-card">
                        <div class="card-icon">üíä</div>
                        <div class="card-title">Common Drugs</div>
                        <p style="color: #64748b;">Cisplatin, carboplatin, pemetrexed, docetaxel. Often used in combinations.</p>
                    </div>
                </div>

                <div style="background: white; padding: 2rem; border-radius: 20px; border: 2px solid #e2e8f0; margin-top: 2rem;">
                    <h4 style="color: #0c4a6e; margin-bottom: 1rem;">When Chemotherapy Is Used:</h4>
                    <ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;">
                        <li><strong>Before surgery (neoadjuvant):</strong> Shrink tumor</li>
                        <li><strong>After surgery (adjuvant):</strong> Kill remaining cancer cells</li>
                        <li><strong>Primary treatment:</strong> For advanced cancer</li>
                        <li><strong>With radiation (chemoradiation):</strong> Enhanced effectiveness - standard for limited-stage SCLC</li>
                        <li><strong>Palliative:</strong> Symptom relief, extend life</li>
                    </ul>
                </div>

                <div style="background: linear-gradient(135deg, #fef2f2 0%, #fee2e2 100%); padding: 2rem; border-radius: 20px; margin-top: 2rem;">
                    <h4 style="color: #991b1b; margin-bottom: 1rem;">‚ö° SCLC-Specific Chemotherapy Approach</h4>
                    <p style="color: #64748b; line-height: 1.8; margin-bottom: 1rem;">SCLC responds very well to chemotherapy initially, but resistance can develop. Treatment differs by stage:</p>
                    
                    <div style="background: white; padding: 1.5rem; border-radius: 12px; margin-bottom: 1rem;">
                        <h5 style="color: #0c4a6e; margin-bottom: 0.5rem;">Limited-Stage SCLC:</h5>
                        <ul style="color: #64748b; margin-left: 1.5rem; line-height: 1.8;">
                            <li><strong>Combination chemoradiation:</strong> Chemotherapy + thoracic radiation (standard)</li>
                            <li>Chemotherapy alone if radiation not possible</li>
                            <li>Surgery + adjuvant chemo ¬± radiation (selected early cases)</li>
                            <li><strong>Prophylactic Cranial Irradiation (PCI):</strong> After complete response to prevent brain metastases</li>
                        </ul>
                    </div>

                    <div style="background: white; padding: 1.5rem; border-radius: 12px;">
                        <h5 style="color: #0c4a6e; margin-bottom: 0.5rem;">Extensive-Stage SCLC:</h5>
                        <ul style="color: #64748b; margin-left: 1.5rem; line-height: 1.8;">
                            <li>Systemic combination chemotherapy (primary treatment)</li>
                            <li>Thoracic radiation in responsive cases</li>
                            <li>Prophylactic cranial irradiation in selected patients</li>
                            <li>Immunotherapy (checkpoint inhibitors) often added</li>
                        </ul>
                    </div>
                </div>

                <div style="background: #f0f9ff; padding: 1.5rem; border-radius: 12px; margin-top: 1rem;">
                    <h5 style="color: #0c4a6e; margin-bottom: 0.5rem;">‚ö†Ô∏è Possible Side Effects:</h5>
                    <p style="color: #64748b; line-height: 1.8;">Nausea, fatigue, hair loss, increased infection risk, anemia. Most are temporary and manageable with supportive care.</p>
                </div>
            </div>

            <!-- Radiation Tab -->
            <div id="radiation-tab" class="tab-content">
                <h3 style="color: #0c4a6e; font-size: 2rem; margin-bottom: 2rem;">‚ò¢Ô∏è Radiation Therapy</h3>
                
                <div class="accordion">
                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>External Beam Radiation (EBRT)</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p><strong>Most common type.</strong> High-energy rays directed at cancer from outside the body.</p>
                            <p><strong>Schedule:</strong> Usually 5 days/week for 5-7 weeks</p>
                            <p><strong>Session length:</strong> 15-30 minutes</p>
                            <p><strong>Pain:</strong> Painless, like getting an X-ray</p>
                        </div>
                    </div>

                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>Stereotactic Body Radiation (SBRT)</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p><strong>High-precision radiation</strong> delivered in fewer, higher doses.</p>
                            <p><strong>Schedule:</strong> 1-5 treatments total</p>
                            <p><strong>Best for:</strong> Early-stage patients who can't have surgery</p>
                            <p><strong>Advantage:</strong> Minimizes damage to healthy tissue</p>
                        </div>
                    </div>

                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>Prophylactic Cranial Irradiation (PCI) - SCLC Specific</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p><strong>Preventive brain radiation for SCLC patients</strong> who respond completely to initial treatment.</p>
                            <p><strong>Purpose:</strong> SCLC frequently metastasizes to the brain. PCI significantly reduces risk of brain metastases.</p>
                            <p><strong>When used:</strong> After complete or good partial response to chemotherapy</p>
                            <p><strong>Benefit:</strong> Improves overall survival in limited-stage SCLC</p>
                        </div>
                    </div>

                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>Palliative Radiation</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p><strong>Used for symptom relief</strong> rather than cure.</p>
                            <p><strong>Applications:</strong></p>
                            <ul style="margin-left: 1.5rem; margin-top: 0.5rem;">
                                <li>Relieve airway obstruction</li>
                                <li>Reduce pain from bone metastases</li>
                                <li>Control bleeding</li>
                                <li>Shrink brain metastases</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <div style="background: linear-gradient(135deg, #fef2f2 0%, #fee2e2 100%); padding: 2rem; border-radius: 12px; margin-top: 2rem;">
                    <h4 style="color: #991b1b; margin-bottom: 1rem;">‚ö° Chemoradiation for SCLC</h4>
                    <p style="color: #64748b; line-height: 1.8;">For limited-stage SCLC, <strong>concurrent chemoradiation</strong> (chemotherapy + thoracic radiation given together) is the standard of care. This combination approach significantly improves survival compared to chemotherapy alone.</p>
                </div>
            </div>

            <!-- Targeted Therapy Tab -->
            <div id="targeted-tab" class="tab-content">
                <h3 style="color: #0c4a6e; font-size: 2rem; margin-bottom: 2rem;">üéØ Targeted Therapy: Precision Medicine</h3>
                <p style="color: #64748b; font-size: 1.1rem; line-height: 1.8; margin-bottom: 2rem;">Drugs that target specific genetic mutations in cancer cells. Requires genetic testing of tumor.</p>

                <div class="card-grid">
                    <div class="interactive-card">
                        <div class="card-icon">üß¨</div>
                        <div class="card-title">EGFR Inhibitors</div>
                        <p style="color: #64748b; margin-bottom: 0.5rem;">For EGFR mutation (10-15% of patients)</p>
                        <p style="color: #64748b; font-size: 0.9rem;"><strong>Drugs:</strong> Osimertinib, Erlotinib</p>
                    </div>

                    <div class="interactive-card">
                        <div class="card-icon">üî¨</div>
                        <div class="card-title">ALK Inhibitors</div>
                        <p style="color: #64748b; margin-bottom: 0.5rem;">For ALK rearrangement (5% of patients)</p>
                        <p style="color: #64748b; font-size: 0.9rem;"><strong>Drugs:</strong> Alectinib, Crizotinib</p>
                    </div>

                    <div class="interactive-card">
                        <div class="card-icon">üíä</div>
                        <div class="card-title">ROS1 Inhibitors</div>
                        <p style="color: #64748b; margin-bottom: 0.5rem;">For ROS1 rearrangement (1-2% of patients)</p>
                        <p style="color: #64748b; font-size: 0.9rem;"><strong>Drugs:</strong> Entrectinib, Crizotinib</p>
                    </div>

                    <div class="interactive-card">
                        <div class="card-icon">üéØ</div>
                        <div class="card-title">BRAF Inhibitors</div>
                        <p style="color: #64748b; margin-bottom: 0.5rem;">For BRAF V600E mutation</p>
                        <p style="color: #64748b; font-size: 0.9rem;"><strong>Drugs:</strong> Dabrafenib + Trametinib</p>
                    </div>

                    <div class="interactive-card">
                        <div class="card-icon">üß™</div>
                        <div class="card-title">KRAS G12C Inhibitors</div>
                        <p style="color: #64748b; margin-bottom: 0.5rem;">Newest breakthrough (approved 2021)</p>
                        <p style="color: #64748b; font-size: 0.9rem;"><strong>Drugs:</strong> Sotorasib, Adagrasib</p>
                    </div>

                    <div class="interactive-card">
                        <div class="card-icon">ü©∏</div>
                        <div class="card-title">Angiogenesis Inhibitors</div>
                        <p style="color: #64748b; margin-bottom: 0.5rem;">Block blood vessel growth to tumors</p>
                        <p style="color: #64748b; font-size: 0.9rem;"><strong>Drugs:</strong> Bevacizumab, Ramucirumab</p>
                    </div>
                </div>

                <div style="background: #fef9e7; border-left: 4px solid #f59e0b; padding: 2rem; border-radius: 12px; margin-top: 2rem;">
                    <h4 style="color: #92400e; margin-bottom: 1rem;">üí° Why Targeted Therapy Matters</h4>
                    <ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;">
                        <li><strong>More effective:</strong> Response rates 60-80% vs 20-30% for chemo</li>
                        <li><strong>Fewer side effects:</strong> Targets cancer cells specifically</li>
                        <li><strong>Oral medication:</strong> Pills taken at home, not IV infusion</li>
                        <li><strong>Better quality of life:</strong> Continue daily activities</li>
                    </ul>
                </div>
            </div>

            <!-- Immunotherapy Tab -->
            <div id="immuno-tab" class="tab-content">
                <h3 style="color: #0c4a6e; font-size: 2rem; margin-bottom: 2rem;">üõ°Ô∏è Immunotherapy: Harnessing Your Immune System</h3>
                <p style="color: #64748b; font-size: 1.1rem; line-height: 1.8; margin-bottom: 2rem;">Revolutionary treatment that helps your immune system recognize and destroy cancer cells. Game-changing results for many patients.</p>

                <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 2rem; margin-bottom: 2rem;">
                    <div style="background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%); padding: 2rem; border-radius: 20px;">
                        <h4 style="color: #0c4a6e; margin-bottom: 1rem;">How It Works</h4>
                        <p style="color: #64748b; line-height: 1.8;">Cancer cells hide from the immune system using "checkpoint" proteins. Immunotherapy blocks these checkpoints, allowing immune cells to attack the cancer.</p>
                    </div>

                    <div style="background: linear-gradient(135deg, #f0fdf4 0%, #dcfce7 100%); padding: 2rem; border-radius: 20px;">
                        <h4 style="color: #0c4a6e; margin-bottom: 1rem;">Success Rates</h4>
                        <p style="color: #64748b; line-height: 1.8;">20-30% of patients have significant, long-lasting responses. Some patients remain cancer-free for years after stopping treatment.</p>
                    </div>
                </div>

                <h4 style="color: #0c4a6e; font-size: 1.5rem; margin-bottom: 1.5rem;">Main Types of Immunotherapy:</h4>

                <div class="accordion">
                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>PD-1/PD-L1 Inhibitors (Most Common)</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p><strong>Mechanism:</strong> Block PD-1 or PD-L1 proteins that cancer uses to hide</p>
                            <p><strong>Drugs:</strong></p>
                            <ul style="margin-left: 1.5rem; margin-top: 0.5rem;">
                                <li><strong>Pembrolizumab (Keytruda):</strong> First-line treatment for many patients</li>
                                <li><strong>Nivolumab (Opdivo):</strong> Used alone or with chemotherapy</li>
                                <li><strong>Atezolizumab (Tecentriq):</strong> Combined with chemo</li>
                                <li><strong>Durvalumab (Imfinzi):</strong> Maintenance after chemo/radiation</li>
                            </ul>
                            <p style="margin-top: 1rem;"><strong>Given:</strong> IV infusion every 2-6 weeks</p>
                        </div>
                    </div>

                    <div class="accordion-item">
                        <div class="accordion-header" onclick="toggleAccordion(this)">
                            <span>CTLA-4 Inhibitors</span>
                            <span class="accordion-icon">‚ñº</span>
                        </div>
                        <div class="accordion-content">
                            <p><strong>Drug:</strong> Ipilimumab (Yervoy)</p>
                            <p><strong>Use:</strong> Sometimes combined with PD-1 inhibitors for advanced cancer</p>
                            <p><strong>Note:</strong> More side effects but can boost effectiveness</p>
                        </div>
                    </div>
                </div>

                <div style="background: #ecfdf5; border-left: 4px solid #10b981; padding: 2rem; border-radius: 12px; margin-top: 2rem;">
                    <h4 style="color: #065f46; margin-bottom: 1rem;">‚ú® Breakthrough Benefits</h4>
                    <ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;">
                        <li><strong>Durable responses:</strong> Can last years after stopping treatment</li>
                        <li><strong>Works for advanced cancer:</strong> Even Stage IV can respond</li>
                        <li><strong>Combination power:</strong> Enhanced when paired with chemotherapy</li>
                        <li><strong>Quality of life:</strong> Generally fewer side effects than chemo</li>
                    </ul>
                </div>
            </div>
        </div>
    </div>

    <!-- RESOURCES PAGE -->
    <div id="resources" class="page">
        <div class="content-page">
            <div class="page-header">
                <h1>Support & Resources</h1>
                <p style="font-size: 1.2rem; color: #64748b;">You're not alone. Connect with organizations, find support, and access helpful tools.</p>
            </div>

            <!-- Quick Links -->
            <div class="card-grid">
                <div class="interactive-card" onclick="openModal('aecc')">
                    <div class="card-icon">üè•</div>
                    <div class="card-title">AECC - Asociaci√≥n Espa√±ola</div>
                    <p style="color: #64748b;">Organizaci√≥n l√≠der en Espa√±a contra el c√°ncer. 24/7 apoyo gratuito.</p>
                    <p style="color: #0ea5e9; font-weight: 600; margin-top: 1rem;">M√°s informaci√≥n ‚Üí</p>
                </div>

                <div class="interactive-card" onclick="openModal('lcfa')">
                    <div class="card-icon">üíô</div>
                    <div class="card-title">Fundaci√≥n M√°s Que Ideas</div>
                    <p style="color: #64748b;">Apoyo a pacientes, investigaci√≥n y programas educativos en Espa√±a.</p>
                    <p style="color: #0ea5e9; font-weight: 600; margin-top: 1rem;">M√°s informaci√≥n ‚Üí</p>
                </div>

                <div class="interactive-card" onclick="openModal('support')">
                    <div class="card-icon">ü§ù</div>
                    <div class="card-title">Support Groups</div>
                    <p style="color: #64748b;">Connect with survivors and caregivers who understand your journey.</p>
                    <p style="color: #0ea5e9; font-weight: 600; margin-top: 1rem;">Find a group ‚Üí</p>
                </div>

                <div class="interactive-card" onclick="openModal('financial')">
                    <div class="card-icon">üí∞</div>
                    <div class="card-title">Financial Assistance</div>
                    <p style="color: #64748b;">Help with treatment costs, medications, travel, and living expenses.</p>
                    <p style="color: #0ea5e9; font-weight: 600; margin-top: 1rem;">Get help ‚Üí</p>
                </div>

                <div class="interactive-card" onclick="openModal('clinical')">
                    <div class="card-icon">üß™</div>
                    <div class="card-title">Clinical Trials</div>
                    <p style="color: #64748b;">Access cutting-edge treatments not yet widely available.</p>
                    <p style="color: #0ea5e9; font-weight: 600; margin-top: 1rem;">Search trials ‚Üí</p>
                </div>

                <div class="interactive-card" onclick="openModal('caregivers')">
                    <div class="card-icon">üë®‚Äçüë©‚Äçüëß</div>
                    <div class="card-title">Caregiver Resources</div>
                    <p style="color: #64748b;">Support and tools for family members and caregivers.</p>
                    <p style="color: #0ea5e9; font-weight: 600; margin-top: 1rem;">Get support ‚Üí</p>
                </div>
            </div>

            <!-- FAQ Section -->
            <div class="faq-section" style="margin-top: 4rem; padding-top: 4rem;">
                <h3 style="color: #0c4a6e; font-size: 2rem; text-align: center; margin-bottom: 3rem;">Frequently Asked Questions</h3>
                
                <div style="max-width: 900px; margin: 0 auto;">
                    <div class="accordion">
                        <div class="accordion-item">
                            <div class="accordion-header" onclick="toggleAccordion(this)">
                                <span>What are the first signs of lung cancer?</span>
                                <span class="accordion-icon">‚ñº</span>
                            </div>
                            <div class="accordion-content">
                                <p>Early signs include persistent cough (lasting 2-3+ weeks), shortness of breath, chest pain, and coughing up blood. However, early-stage lung cancer often has no symptoms, which is why screening is so important for high-risk individuals.</p>
                            </div>
                        </div>

                        <div class="accordion-item">
                            <div class="accordion-header" onclick="toggleAccordion(this)">
                                <span>Can non-smokers get lung cancer?</span>
                                <span class="accordion-icon">‚ñº</span>
                            </div>
                            <div class="accordion-content">
                                <p>Yes. About 10-20% of lung cancer patients never smoked. Risk factors for non-smokers include secondhand smoke, radon exposure, air pollution, family history, and occupational exposures (asbestos, diesel exhaust).</p>
                            </div>
                        </div>

                        <div class="accordion-item">
                            <div class="accordion-header" onclick="toggleAccordion(this)">
                                <span>How is lung cancer detected early?</span>
                                <span class="accordion-icon">‚ñº</span>
                            </div>
                            <div class="accordion-content">
                                <p>Annual low-dose CT screening is recommended for adults 55-80 who are current or former heavy smokers (30+ pack-years). This screening can detect cancer when it's small and most treatable, reducing death risk by 20%.</p>
                            </div>
                        </div>

                        <div class="accordion-item">
                            <div class="accordion-header" onclick="toggleAccordion(this)">
                                <span>What's the survival rate for lung cancer?</span>
                                <span class="accordion-icon">‚ñº</span>
                            </div>
                            <div class="accordion-content">
                                <p>Survival depends heavily on stage at diagnosis. Stage I: 60-70%. Stage II: 40-50%. Stage III: 15-30%. Stage IV: 5-10%. Overall 5-year survival is about 23%, but this is improving with new treatments like immunotherapy and targeted therapy.</p>
                            </div>
                        </div>

                        <div class="accordion-item">
                            <div class="accordion-header" onclick="toggleAccordion(this)">
                                <span>Is lung cancer always caused by smoking?</span>
                                <span class="accordion-icon">‚ñº</span>
                            </div>
                            <div class="accordion-content">
                                <p>No. While smoking causes 85% of cases, other risk factors include radon (2nd leading cause), secondhand smoke, air pollution, occupational exposures, and genetic factors. However, quitting smoking at any age significantly reduces risk.</p>
                            </div>
                        </div>

                        <div class="accordion-item">
                            <div class="accordion-header" onclick="toggleAccordion(this)">
                                <span>What are the newest treatment breakthroughs?</span>
                                <span class="accordion-icon">‚ñº</span>
                            </div>
                            <div class="accordion-content">
                                <p>Major advances include: immunotherapy (checkpoint inhibitors), targeted therapies for specific mutations (EGFR, ALK, KRAS G12C), liquid biopsies for early detection, and AI-assisted diagnosis. These have dramatically improved outcomes, especially for advanced-stage patients.</p>
                            </div>
                        </div>

                        <div class="accordion-item">
                            <div class="accordion-header" onclick="toggleAccordion(this)">
                                <span>Should I get genetic testing?</span>
                                <span class="accordion-icon">‚ñº</span>
                            </div>
                            <div class="accordion-content">
                                <p>Yes! All advanced NSCLC patients should get molecular/genetic testing. It identifies targetable mutations (EGFR, ALK, ROS1, BRAF, KRAS, etc.) that can be treated with highly effective targeted therapies. Testing helps personalize treatment.</p>
                            </div>
                        </div>

                        <div class="accordion-item">
                            <div class="accordion-header" onclick="toggleAccordion(this)">
                                <span>How can I reduce my risk?</span>
                                <span class="accordion-icon">‚ñº</span>
                            </div>
                            <div class="accordion-content">
                                <p>Key steps: Don't smoke (or quit immediately), test home for radon, avoid secondhand smoke, use protective equipment if exposed to carcinogens at work, eat healthy diet rich in fruits/vegetables, exercise regularly, and get screened if high-risk.</p>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Emergency Helplines -->
            <div style="background: linear-gradient(135deg, #fef2f2 0%, #fee2e2 100%); padding: 3rem; border-radius: 24px; margin-top: 4rem; text-align: center;">
                <h3 style="color: #991b1b; font-size: 2rem; margin-bottom: 1.5rem;">üìû ¬øNecesitas Ayuda Inmediata? / Need Immediate Support?</h3>
                <p style="color: #64748b; font-size: 1.1rem; margin-bottom: 2rem;">L√≠neas de ayuda en Espa√±a / Spanish Support Lines</p>
                <div style="display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 1.5rem;">
                    <div style="background: white; padding: 1.5rem; border-radius: 16px;">
                        <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">AECC (Asociaci√≥n Espa√±ola Contra el C√°ncer)</h4>
                        <p style="color: #0ea5e9; font-size: 1.5rem; font-weight: 700; margin-bottom: 0.5rem;">900 100 036</p>
                        <p style="color: #64748b; font-size: 0.9rem;">Atenci√≥n 24h, gratuita</p>
                    </div>
                    <div style="background: white; padding: 1.5rem; border-radius: 16px;">
                        <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">SEPAR (Neumolog√≠a)</h4>
                        <p style="color: #0ea5e9; font-size: 1.5rem; font-weight: 700; margin-bottom: 0.5rem;">91 535 9372</p>
                        <p style="color: #64748b; font-size: 0.9rem;">Sociedad Espa√±ola de Neumolog√≠a</p>
                    </div>
                    <div style="background: white; padding: 1.5rem; border-radius: 16px;">
                        <h4 style="color: #0c4a6e; margin-bottom: 0.5rem;">Dejar de Fumar</h4>
                        <p style="color: #0ea5e9; font-size: 1.5rem; font-weight: 700; margin-bottom: 0.5rem;">900 850 300</p>
                        <p style="color: #64748b; font-size: 0.9rem;">L√≠nea para dejar de fumar</p>
                    </div>
                </div>
                <div style="margin-top: 2rem; padding: 1.5rem; background: white; border-radius: 16px;">
                    <h4 style="color: #0c4a6e; margin-bottom: 1rem;">üè• M√°s Recursos en Espa√±a:</h4>
                    <div style="color: #64748b; text-align: left; max-width: 600px; margin: 0 auto;">
                        <p><strong>‚Ä¢ Fundaci√≥n M√°s Que Ideas:</strong> Apoyo a pacientes de c√°ncer de pulm√≥n</p>
                        <p><strong>‚Ä¢ GECP:</strong> Grupo Espa√±ol de C√°ncer de Pulm√≥n (investigaci√≥n)</p>
                        <p><strong>‚Ä¢ Hospitales de referencia:</strong> Hospital La Paz (Madrid), Hospital Cl√≠nic (Barcelona), Hospital Universitario La Fe (Valencia)</p>
                        <p><strong>‚Ä¢ Web AECC:</strong> www.aecc.es</p>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- Modals -->
    <div id="modal" class="modal">
        <div class="modal-content">
            <span class="modal-close" onclick="closeModal()">√ó</span>
            <div id="modalBody"></div>
        </div>
    </div>

    <script>
        // Page Navigation
        function showPage(pageId) {
            document.querySelectorAll('.page').forEach(page => page.classList.remove('active'));
            document.getElementById(pageId).classList.add('active');
            
            document.querySelectorAll('.nav-link').forEach(link => {
                link.classList.remove('active');
                if (link.dataset.page === pageId) link.classList.add('active');
            });
            
            window.scrollTo({ top: 0, behavior: 'smooth' });
        }

        // Tab Switching
        function switchTab(tabId) {
            const parentPage = document.querySelector('.page.active');
            parentPage.querySelectorAll('.tab').forEach(tab => tab.classList.remove('active'));
            parentPage.querySelectorAll('.tab-content').forEach(content => content.classList.remove('active'));
            
            event.target.classList.add('active');
            parentPage.querySelector(`#${tabId}`).classList.add('active');
        }

        // Accordion Toggle
        function toggleAccordion(header) {
            const item = header.parentElement;
            const content = header.nextElementSibling;
            const isActive = item.classList.contains('active');
            
            document.querySelectorAll('.accordion-item').forEach(i => {
                i.classList.remove('active');
                i.querySelector('.accordion-content').style.maxHeight = null;
            });
            
            if (!isActive) {
                item.classList.add('active');
                content.style.maxHeight = content.scrollHeight + 'px';
            }
        }

        // Testimonial Slider
        let currentTestimonial = 0;
        const testimonials = document.querySelectorAll('.testimonial');

        function changeTestimonial(direction) {
            testimonials[currentTestimonial].classList.remove('active');
            currentTestimonial = (currentTestimonial + direction + testimonials.length) % testimonials.length;
            testimonials[currentTestimonial].classList.add('active');
        }

        // Auto-rotate testimonials
        setInterval(() => changeTestimonial(1), 6000);

        // Animated Counter
        function animateCounter(element) {
            const target = parseInt(element.dataset.target);
            const duration = 2000;
            const increment = target / (duration / 16);
            let current = 0;

            const timer = setInterval(() => {
                current += increment;
                if (current >= target) {
                    element.textContent = target.toLocaleString();
                    clearInterval(timer);
                } else {
                    element.textContent = Math.floor(current).toLocaleString();
                }
            }, 16);
        }

        // Trigger counters when visible
        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting && entry.target.textContent === '0') {
                    animateCounter(entry.target);
                }
            });
        });

        document.querySelectorAll('.stat-number').forEach(el => observer.observe(el));

        // Risk Calculator
        function calculateRisk() {
            const smoking = parseInt(document.getElementById('smoking').value);
            const age = parseInt(document.getElementById('age').value);
            const secondhand = parseInt(document.getElementById('secondhand').value);
            const family = parseInt(document.getElementById('family').value);
            const occupational = parseInt(document.getElementById('occupational').value);
            
            const total = smoking + age + secondhand + family + occupational;
            const result = document.getElementById('riskResult');
            const level = document.getElementById('riskLevel');
            const advice = document.getElementById('riskAdvice');
            
            let riskText, riskClass, adviceText;
            
            if (total <= 5) {
                riskText = 'LOW RISK';
                riskClass = 'risk-low';
                adviceText = 'Great news! Your risk is relatively low. Maintain a healthy lifestyle with regular exercise, a balanced diet, and avoid smoking. Continue these healthy habits!';
            } else if (total <= 15) {
                riskText = 'MODERATE RISK';
                riskClass = 'risk-medium';
                adviceText = 'You have some risk factors. Consider: quitting smoking if applicable, testing your home for radon, discussing screening with your doctor (especially if 55+), and reducing exposure to secondhand smoke and occupational hazards.';
            } else {
                riskText = 'HIGH RISK';
                riskClass = 'risk-high';
                adviceText = 'Your risk factors are significant. STRONGLY RECOMMENDED: Talk to your doctor about lung cancer screening (low-dose CT scan), quit smoking immediately if you smoke, test for radon, and discuss preventive strategies with a healthcare provider. Early detection is crucial.';
            }
            
            level.textContent = riskText;
            level.className = `risk-level ${riskClass}`;
            advice.textContent = adviceText;
            result.classList.add('show');
            
            result.scrollIntoView({ behavior: 'smooth', block: 'nearest' });
        }

        // Modal Functions
        function openModal(type) {
            const modal = document.getElementById('modal');
            const body = document.getElementById('modalBody');
            
            const content = {
                'nsclc': '<h2 style="color: #0c4a6e; margin-bottom: 1rem;">Non-Small Cell Lung Cancer (NSCLC)</h2><p style="color: #64748b; line-height: 1.8; margin-bottom: 1rem;">NSCLC accounts for 80-85% of lung cancer cases. It grows more slowly than small cell lung cancer and has three main subtypes:</p><ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;"><li><strong>Adenocarcinoma (40%):</strong> Most common. Usually in outer lung regions. Can originate from AT2 cells, bronchioalveolar stem cells, Club cells, or basal cells.</li><li><strong>Squamous Cell Carcinoma (25-30%):</strong> Forms in central airways from basal cells. Large, polygonal cells with keratinization. Strongly linked to smoking.</li><li><strong>Large Cell Carcinoma (10-15%):</strong> Undifferentiated, lacking features of other types. About 37% have targetable mutations (mainly KRAS).</li></ul><p style="color: #64748b; margin-top: 1rem;">Treatment options include surgery, chemotherapy, radiation, targeted therapy, or immunotherapy depending on the stage and molecular profile.</p>',
                
                'sclc': '<h2 style="color: #0c4a6e; margin-bottom: 1rem;">Small Cell Lung Cancer (SCLC)</h2><p style="color: #64748b; line-height: 1.8; margin-bottom: 1rem;">SCLC represents 15-20% of cases. It\'s a high-grade neuroendocrine carcinoma that is extremely aggressive and grows rapidly.</p><p style="color: #64748b; line-height: 1.8; margin-bottom: 1rem;"><strong>Cell Characteristics:</strong> Very small round-to-fusiform cells, extremely high nucleus-to-cytoplasm ratio, "salt and pepper" chromatin, high mitotic rate, and extensive necrosis.</p><p style="color: #64748b; line-height: 1.8; margin-bottom: 1rem;"><strong>Origin:</strong> Previously believed to be pulmonary neuroendocrine cells (PNEC). New research suggests <strong>lung basal cells</strong>, especially for tuft-like SCLC-P tumors.</p><h4 style="color: #0c4a6e; margin: 1rem 0 0.5rem;">Four Molecular Subtypes:</h4><ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;"><li><strong>SCLC-A (ASCL1+):</strong> Classic neuroendocrine, most common</li><li><strong>SCLC-N (NEUROD1+):</strong> Neuronal features</li><li><strong style="color: #ef4444;">SCLC-P (POU2F3+):</strong> Tuft-like, WORST PROGNOSIS, most aggressive</li><li><strong>SCLC-Y (YAP1+):</strong> Inflammatory, basal-like</li></ul><p style="color: #64748b; line-height: 1.8; margin-top: 1rem;"><strong>Key Mutations:</strong> Nearly universal RB1 and TP53 loss. SCLC-P has 56% MYC amplification and 63% PTEN loss.</p><p style="color: #64748b; line-height: 1.8; margin-top: 1rem;"><strong>Special Features:</strong> Spreads quickly to lymph nodes, bones, brain, liver, adrenal glands. Can cause paraneoplastic syndromes (SIADH, Cushing\'s, Lambert-Eaton). May cause fluid buildup in lungs.</p><p style="color: #64748b; line-height: 1.8;">Treatment: Responds very well to chemotherapy initially. Limited-stage: chemoradiation + PCI. Extensive-stage: chemotherapy + immunotherapy.</p>',
                
                'rare': '<h2 style="color: #0c4a6e; margin-bottom: 1rem;">Rare Lung Cancer Types</h2><p style="color: #64748b; line-height: 1.8;">Includes carcinoid tumors (slow-growing, often curable), adenoid cystic carcinomas, lymphomas, and sarcomas. These require specialized treatment approaches. Consult with specialists experienced in rare lung cancers.</p>',
                
                'aecc': '<h2 style="color: #0c4a6e; margin-bottom: 1rem;">AECC - Asociaci√≥n Espa√±ola Contra el C√°ncer</h2><p style="color: #64748b; line-height: 1.8; margin-bottom: 1rem;">La organizaci√≥n l√≠der en Espa√±a dedicada a la lucha contra el c√°ncer. Servicios incluyen:</p><ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;"><li>L√≠nea de Ayuda 24/7: 900 100 036 (gratuita)</li><li>Recursos educativos gratuitos</li><li>Grupos de apoyo en toda Espa√±a</li><li>Programas para dejar de fumar</li><li>Financiaci√≥n de investigaci√≥n</li><li>Ayuda psicol√≥gica</li><li>Apoyo social y econ√≥mico</li></ul><p style="color: #0ea5e9; margin-top: 1rem;"><strong>Web:</strong> www.aecc.es</p>',
                
                'lcfa': '<h2 style="color: #0c4a6e; margin-bottom: 1rem;">Fundaci√≥n M√°s Que Ideas</h2><p style="color: #64748b; line-height: 1.8;">Fundaci√≥n espa√±ola dedicada al apoyo de pacientes con c√°ncer de pulm√≥n y financiaci√≥n de investigaci√≥n. Programas incluyen navegaci√≥n de pacientes, webinarios educativos y asistencia econ√≥mica.</p><p style="color: #0ea5e9; margin-top: 1rem;"><strong>Tambi√©n:</strong> GECP (Grupo Espa√±ol de C√°ncer de Pulm√≥n) - Investigaci√≥n y avances m√©dicos</p>',
                
                'support': '<h2 style="color: #0c4a6e; margin-bottom: 1rem;">Grupos de Apoyo en Espa√±a</h2><p style="color: #64748b; line-height: 1.8; margin-bottom: 1rem;">Conecta con otros que entienden tu situaci√≥n:</p><ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;"><li>Grupos de apoyo AECC en toda Espa√±a</li><li>Comunidades online en espa√±ol</li><li>Programas de mentor√≠a con supervivientes</li><li>Redes de apoyo para cuidadores</li><li>Asociaciones de pacientes locales</li></ul><p style="color: #0ea5e9; margin-top: 1rem;"><strong>Contacto:</strong> 900 100 036</p>',
                
                'financial': '<h2 style="color: #0c4a6e; margin-bottom: 1rem;">Ayuda Econ√≥mica en Espa√±a</h2><ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;"><li><strong>AECC:</strong> Ayudas econ√≥micas y apoyo social</li><li><strong>Seguridad Social:</strong> Cobertura de tratamientos oncol√≥gicos</li><li><strong>Incapacidad Temporal:</strong> Durante el tratamiento</li><li><strong>Ayudas auton√≥micas:</strong> Cada comunidad ofrece apoyo adicional</li><li><strong>Fundaciones:</strong> Ayuda para gastos de desplazamiento y alojamiento</li><li><strong>Programas farmac√©uticos:</strong> Acceso a medicamentos</li></ul><p style="color: #0ea5e9; margin-top: 1rem;"><strong>Info:</strong> Trabajador social del hospital o AECC</p>',
                
                'clinical': '<h2 style="color: #0c4a6e; margin-bottom: 1rem;">Ensayos Cl√≠nicos en Espa√±a</h2><p style="color: #64748b; line-height: 1.8; margin-bottom: 1rem;">Acceso a tratamientos de vanguardia:</p><ul style="color: #64748b; margin-left: 1.5rem; line-height: 2;"><li><strong>REEC:</strong> Registro Espa√±ol de Estudios Cl√≠nicos (reec.aemps.es)</li><li>Ensayos en hospitales espa√±oles principales</li><li>GECP - Grupo Espa√±ol de C√°ncer de Pulm√≥n</li><li>Consulta con tu onc√≥logo sobre opciones</li><li>Hospital La Paz, Hospital Cl√≠nic, Hospital La Fe</li></ul>',
                
                'caregivers': '<h2 style="color: #0c4a6e; margin-bottom: 1rem;">Caregiver Resources</h2><p style="color: #64748b; line-height: 1.8;">Supporting someone with lung cancer is challenging. Resources include:</p><ul style="color: #64748b; margin-left: 1.5rem; line-height: 2; margin-top: 1rem;"><li>Caregiver support groups</li><li>Respite care services</li><li>Educational resources</li><li>Self-care guidance</li><li>Financial planning assistance</li></ul>'
            };
            
            body.innerHTML = content[type] || '<p>Information coming soon.</p>';
            modal.classList.add('show');
        }

        function closeModal() {
            document.getElementById('modal').classList.remove('show');
        }

        // Close modal on outside click
        window.onclick = function(event) {
            const modal = document.getElementById('modal');
            if (event.target === modal) {
                closeModal();
            }
        }

        // Search functionality
        document.getElementById('aboutSearch')?.addEventListener('input', function(e) {
            const searchTerm = e.target.value.toLowerCase();
            // Simple search implementation - could be expanded
            if (searchTerm.length > 2) {
                console.log('Searching for:', searchTerm);
                // In a real app, this would filter content
            }
        });
    </script>
</body>
</html>